Down-regulation of TIPE2 mRNA expression in peripheral blood mononuclear cells from patients with systemic lupus erythematosus

Clinical Immunology

Volumn 133, Issue 3, 2009, Pages 422-427

  Li, Di ^a   Song, Lijun ^a   Fan, Yuchen ^a   Li, Xia ^b   Li, Yingjie ^a   Chen, Jie ^a   Zhu, Faliang ^a   Guo, Chun ^a   Shi, Yongyu ^a   Zhang, Lining ^a  

^a SHANDONG UNIVERSITY   (China)

^b Department of Neurosurgery   (China)

Author keywords

Disease activity; Myxoma resistance protein 1; Real time reverse transcription polymerase chain reaction analysis; Systemic lupus erythematosus; Tumor necrosis factor induced protein 8 like 2; Type I interferon

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; INTERFERON; MESSENGER RNA; MYXOMA RESISTANCE PROTEIN 1; PROTEIN; PROTEIN DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INDUCED PROTEIN 8 LIKE 2; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; MALE; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCORING SYSTEM; SYSTEMIC LUPUS ERYTHEMATOSUS; TIPE2 GENE;

ADOLESCENT; ADULT; DOWN-REGULATION; FEMALE; GTP-BINDING PROTEINS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LEUKOCYTES, MONONUCLEAR; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STATISTICS, NONPARAMETRIC; YOUNG ADULT;

EID: 70350576616     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2009.08.014     Document Type: Article

References (32)

1. Crispín J.C., Kyttaris V., Juang Y.T., and Tsokos G.C. Systemic lupus erythematosus: new molecular targets. Ann. Rheum. Dis. 66 (2007) 65-69
2. Sun H., Gong S., Carmody R.J., Hilliard A., Li L., Sun J., Kong L., Xu L., Hilliard B., Hu S., Shen H., Yang X., and Chen Y.H. TIPE2, a negative regulator of innate and adaptive immunity that maintains immune homeostasis. Cell 133 (2008) 415-426
3. Hrycek A., Kusmierz D., Dybała T., and Swiatkowska L. Expression of messenger RNA for transforming growth factor-beta1 and for transforming growth factor-beta receptors in peripheral blood of systemic lupus erythematosus patients treated with low doses of quinagolide. Autoimmunity 40 (2007) 23-30
4. Wong C.K., Lit L.C., Tam L.S., Li E.K., and Lam C.W. Aberrant production of soluble costimulatory molecules CTLA-4, CD28, CD80 and CD86 in patients with systemic lupus erythematosus. Rheumatology (Oxford) 44 (2005) 989-994
5. Fujimoto M., Tsutsui H., Xinshou O., Tokumoto M., Watanabe D., Shima Y., Yoshimoto T., Hirakata H., Kawase I., Nakanishi K., Kishimoto T., and Naka T. Inadequate induction of suppressor of cytokine signaling-1 causes systemic autoimmune diseases. Int. Immunol. 16 (2004) 303-314
6. Bates J.S., Lessard C.J., Leon J.M., Nguyen T., Battiest L.J., Rodgers J., Kaufman K.M., James J.A., Gilkeson G.S., Kelly J.A., Humphrey M.B., Harley J.B., Gray-McGuire C., Moser K.L., and Gaffney P.M. Meta-analysis and imputation identifies a 109 kb risk haplotype spanning TNFAIP3 associated with lupus nephritis and hematologic manifestations. Genes Immun. (2009 Apr 23) [Epub ahead of print]
7. Musone S.L., Taylor K.E., Lu T.T., Nititham J., Ferreira R.C., Ortmann W., Shifrin N., Petri M.A., Kamboh M.I., Manzi S., Seldin M.F., Gregersen P.K., Behrens T.W., Ma A., Kwok P.Y., and Criswell L.A. Multiple polymorphisms in the TNFAIP3 region are independently associated with systemic lupus erythematosus. Nat. Genet. 40 (2008) 1062-1064
8. Zhang B., Zhang X., Tang F., Zhu L., and Liu Y. Reduction of forkhead box P3 levels in CD4+CD25high T cells in patients with new-onset systemic lupus erythematosus. Clin. Exp. Immunol. 153 (2008) 182-187
9. Nazareth M., Fanti P., Schwach C., Poppenberg K., Janis K., and Aronica S.M. Altered Bax expression and decreased apoptosis in bone marrow cells of lupus-susceptible NZB/W mice. Lupus 10 (2001) 785-793
10. Hutcheson J., Scatizzi J.C., Siddiqui A.M., Haines GK, Wu T., Li Q.Z., Davis L.S., Mohan C., and Perlman H. Combined deficiency of proapoptotic regulators Bim and Fas results in the early onset of systemic autoimmunity. Immunity 28 (2008) 206-217
11. Sahin M., Aydintug O., Tunc S.E., Tutkak H., and Naziroǧlu M. Serum soluble Fas levels in patients with autoimmune rheumatic diseases. Clin. Biochem. 40 (2007) 6-10
12. Freundt E.C., Bidere N., and Lenardo M.J. A different TIPE of immune homeostasis. Cell 133 (2008) 401-402
13. Zhang X., Wang J., Fan C., Li H., Sun H., Gong S., Chen Y.H., and Shi Y. Crystal structure of TIPE2 provides insights into immune homeostasis. Nat. Struct. Mol. Biol. 16 (2009) 89-90
14. Lee P.Y., Li Y., Richards H.B., Chan F.S., Zhuang H., Narain S., Butfiloski E.J., Sobel E.S., Reeves W.H., Segal M.S., and Type I. Interferon as a novel risk factor for endothelial progenitor cell depletion and endothelial dysfunction in systemic lupus erythematosus. Arthritis Rheum. 56 (2007) 3759-3769
15. Feng X., Wu H., Grossman J.M., Hanvivadhanakul P., FitzGerald J.D., Park G.S., Dong X., Chen W., Kim M.H., Weng H.H., Furst D.E., Gorn A., McMahon M., Taylor M., Brahn E., Hahn B.H., and Tsao B.P. Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus. Arthritis Rheum. 54 (2006) 2951-2962
16. Zhuang H., Narain S., Sobel E., Lee P.Y., Nacionales D.C., Kelly K.M., Richards H.B., Segal M., Stewart C., Satoh M., and Reeves W.H. Association of anti-nucleoprotein autoantibodies with upregulation of Type I interferon-inducible gene transcripts and dendritic cell maturation in systemic lupus erythematosus. Clin. Immunol. 117 (2005) 238-250
17. Hochberg M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 40 (1997) 1725
18. Bombardier C., Gladman D.D., Urowitz M.B., Caron D., and Chang C.H. Derivation of the SLEDAI. A disease activity index for lupus patients, The Committee on Prognosis Studies in SLE. Arthritis Rheum. 35 (1992) 630-640
19. Nagy G., Koncz A., and Perl A. T- and B-cell abnormalities in systemic lupus erythematosus. Crit. Rev. Immunol. 25 (2005) 123-140
20. Peng S.L. Altered T and B lymphocyte signaling pathways in lupus. Autoimmun. Rev. 8 (2009) 179-183
21. Chun h.Y., Chung J.W., Kim h.a., Yun J.M., Jeon J.Y., and Ye Y.M. Cytokine IL-6 and IL-10 as biomarkers in systemic lupus erythematosus. J. Clin. Immunol. 27 (2007) 461-466
22. Lard L.R., Roep B.O., Verburgh C.A., Zwinderman A.H., and Huizinga T.W. Elevated IL-16 levels in patients with systemic lupus erythematosus are associated with disease severity but not with genetic susceptibility to lupus. Lupus 11 (2002) 181-185
23. Lourenço E.V., and La Cava A. Cytokines in systemic lupus erythematosus. Curr. Mol. Med. 9 (2009) 242-254
24. Mellor-Pita S., Citores M.J., Castejon R., Yebra-Bango M., Tutor-Ureta P., Rosado S., Andreu J.L., and Vargas J.A. Monocytes and T lymphocytes contribute to a predominance of interleukin 6 and interleukin 10 in systemic lupus erythematosus. Cytometry. B. Clin. Cytom. (2009 Feb 6) [Epub ahead of print]
25. Pascual V., Farkas L., and Banchereau J. Systemic lupus erythematosus: all roads lead to type I interferons. Curr. Opin. Immunol. 18 (2006) 676-682
26. Koutouzov S., Mathian A., and Dalloul A. Type-I interferons and systemic lupus erythematosus. Autoimmun. Rev. 5 (2006) 554-562
27. Hawiger D., Inaba K., Dorsett Y., Guo M., Mahnke K., Rivera M., Ravetch J.V., Steinman R.M., and Nussenzweig M.C. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. 194 (2001) 769-779
28. Colonna M. TLR pathways and IFN-regulatory factors: to each its own. Eur. J. Immunol. 37 (2007) 306-309
29. Honda K., Yanai H., Negishi H., Asagiri M., Sato M., Mizutani T., Shimada N., Ohba Y., Takaoka A., Yoshida N., and Taniguchi T. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434 (2005) 772-777
30. Arthur A.T., Armati P.J., Bye C., Southern MS Genetics Consortium, Heard R.N., Stewart G.J., Pollard J.D., and Booth D.R. Genes implicated in multiple sclerosis pathogenesis from consilience of genotyping and expression profiles in relapse and remission. BMC Med. Genet. 9 (2008) 17
31. Barreto M., Santos E., Ferreira R., Fesel C., Fontes M.F., Pereira C., Martins B., Andreia R., Viana J.F., Crespo F., Vasconcelos C., Ferreira C., and Vicente A.M. Evidence for CTLA4 as a susceptibility gene for systemic lupus erythematosus. Eur. J. Hum. Genet. 12 (2004) 620-626
32. Bijl M., Horst G., Limburg P.C., and Kallenberg C.G. Fas expression on peripheral blood lymphocytes in systemic lupus erythematosus (SLE): relation to lymphocyte activation and disease activity. Lupus 10 (2001) 866-872